+ H tr iu tr x gan, vim gan do virus B, C, D v gan nhim m: 600 mg 1200mg/ngy, tim tnh mch chm cho n khi hi phc
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) Injection site reactions Headache Fatigue Dizziness Important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be needed) Potential worsening of diabetic retinopathy with semaglutide in patients with pre-existing retinopathy [18] Risk of dehydration and acute kidney injury from persistent vomiting or diarrhoea Pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain) [19] [20] Patients should be counselled about persistent severe abdominal pain as a potential warning sign of pancreatitis requiring immediate medical attention
El tratamiento para la obesidad est cambiando
Where Cuban has reported friction is with brand manufacturers and PBMs blocking direct-to-consumer access to brand drugs and to the specialty distribution channels that PBMs control
2020 Feb 18;11:41
Support goes beyond prescriptions, with tailored health coaching, side effect guidance, and app-based tracking tools included in membership